Cassava Sciences Inc (SAVA)
26.14
+0.96
(+3.81%)
USD |
NASDAQ |
Nov 14, 16:00
26.06
-0.08
(-0.31%)
After-Hours: 07:41
Cassava Sciences Free Cash Flow (Quarterly): -18.31M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -18.31M |
| June 30, 2024 | -18.27M |
| March 31, 2024 | -19.13M |
| December 31, 2023 | -22.36M |
| September 30, 2023 | -26.55M |
| June 30, 2023 | -19.92M |
| March 31, 2023 | -13.61M |
| December 31, 2022 | -20.98M |
| September 30, 2022 | -22.71M |
| June 30, 2022 | -12.58M |
| March 31, 2022 | -23.96M |
| December 31, 2021 | -8.087M |
| September 30, 2021 | -36.80M |
| June 30, 2021 | -5.212M |
| March 31, 2021 | -2.306M |
| December 31, 2020 | -1.175M |
| September 30, 2020 | -2.171M |
| June 30, 2020 | -0.842M |
| March 31, 2020 | -1.194M |
| December 31, 2019 | -0.589M |
| September 30, 2019 | -0.73M |
| June 30, 2019 | -0.591M |
| March 31, 2019 | -0.622M |
| December 31, 2018 | -0.565M |
| September 30, 2018 | -1.436M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.126M |
| March 31, 2018 | -1.643M |
| December 31, 2017 | -1.437M |
| September 30, 2017 | -2.151M |
| June 30, 2017 | -3.197M |
| March 31, 2017 | -1.452M |
| December 31, 2016 | -3.03M |
| September 30, 2016 | -2.863M |
| June 30, 2016 | -3.274M |
| March 31, 2016 | -3.142M |
| December 31, 2015 | -3.548M |
| September 30, 2015 | -2.41M |
| June 30, 2015 | -1.948M |
| March 31, 2015 | -1.342M |
| December 31, 2014 | -2.564M |
| September 30, 2014 | -1.672M |
| June 30, 2014 | -2.591M |
| March 31, 2014 | -2.802M |
| December 31, 2013 | -1.454M |
| September 30, 2013 | -1.819M |
| June 30, 2013 | -1.801M |
| March 31, 2013 | -1.873M |
| December 31, 2012 | -1.854M |
| September 30, 2012 | -1.297M |
| June 30, 2012 | -1.95M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-36.80M
Minimum
Sep 2021
-0.589M
Maximum
Dec 2019
-13.84M
Average
-15.94M
Median
Free Cash Flow (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 5.267B |
| Seelos Therapeutics Inc | -0.972M |
| EyePoint Pharmaceuticals Inc | -40.60M |
| PTC Therapeutics Inc | -87.77M |
| Adverum Biotechnologies Inc | -21.34M |